在垂体腺瘤中非编码RNA和外体非编码RNA
Neda Rahimian1, Amirhossein Sheida2, Mohammadreza Rajabi3
1Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences (IUMS), Tehran, Iran; Department of Internal Medicine, School of Medicine, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.
垂体腺瘤 (PAs) 是一种常见的大脑瘤. 失调的非编码RNAs (ncRNAs) 显示为早期检测的生物标志物和垂体腺瘤的潜在治疗点.
科学领域:
- 内分泌学和瘤学 在内分泌学和瘤学.
- 分子生物学和遗传学分子生物学和遗传学
背景情况:
- 垂体腺瘤 (PA) 是第三个最常见的初级内瘤.
- 由于无症状的性质,PAS往往被诊断为晚期,从而限制了外科手术的有效性.
- 早期发现PAS对于改善患者的治疗结果和管理至关重要.
研究的目的:
- 审查在垂体腺瘤中失调的非编码RNAs (ncRNAs) 的表达模式.
- 探索ncRNAs作为PA诊断的非侵入性生物标志物的潜力.
- 讨论ncRNAs作为PA治疗的潜在治疗点.
主要方法:
- 文献综述总结了PA中的ncRNA表达特征.
- 分析涉及PA的微RNA,长非编码RNA和圆形RNA.
- 讨论由ncRNAs参与PA病变的分子途径.
主要成果:
- 在PA中观察到各种ncRNAs (miRNAs, lncRNAs, circRNAs) 的改变表达特征.
- 这些ncRNAs在PA发育和进展背后的分子机制中发挥作用.
- 失调的ncRNAs代表了新的诊断和治疗策略的有希望的途径.
结论:
- 在垂体腺瘤中,ncRNAs显著失调.
- ncRNA表达模式为开发用于早期PA检测的非侵入性生物标志物提供了潜力.
- ncRNAs可以作为 pituitary adenoma 治疗的创新治疗点.
更多相关视频
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
07:43Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
相关概念视频
lncRNA - Long Non-coding RNAs
Non-LTR Retrotransposons
The Nucleolus
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Types of RNA
RNA Performs Diverse...
piRNA - Piwi-interacting RNAs
